Meta-analysis of Pegfilgrastim over Filgrastim in the Treatment of Chemotherapy-induced Neutropenia-Reference-Cited by-同舟云学术

Meta-analysis of Pegfilgrastim over Filgrastim in the Treatment of Chemotherapy-induced Neutropenia

Published:2020-07-09 Issue:2 Volume:28 Page:71-80
ISSN:1344-6835
Container-title:Annals of Cancer Research and Therapy
language:en
Short-container-title:Ann. Cancer Res. Therap.

Author:

Mohseni Mahsa¹,Arab-Zozani Morteza²,Ahmadi Ayat³,Salimi Babak⁴,Akbari Sari Ali⁵

Affiliation:

1. School of Public Health, Tehran University of Medical Sciences

2. Social Determinants of Health Research Center, Birjand University of Medical Sciences

3. Knowledge Utilization Research Center, Tehran University of Medical Sciences

4. Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and lung Diseases, Shahid Beheshti University of Medical Sciences

5. Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences

Publisher

The Japanese Society of Strategies for Cancer Research and Therapy

Subject

Pharmacology (medical),Cancer Research,Oncology

Link

https://www.jstage.jst.go.jp/article/acrt/28/2/28_71/_pdf

Reference33 articles.

1. 1) Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. European journal of cancer (Oxford, England : 1990). 2011; 47(1): 8–32. doi: 10.1016/j.ejca.2010.10.013

2. 2) Cooper KL, Madan J, Whyte S, Stevenson MD, Akehurst RL. Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis. BMC cancer. 2011; 11: 404.

3. 3) National Comprehensive Cancer Network. Clinical practice guidelines in oncology (NCCN guidelines). Prevention and treatment of cancerrelated infections. 2017 [Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed June 19, 2017.

4. 4) Bennett CL, Djulbegovic B, Norris LB, Armitage JO. Colony-stimulating factors for febrile neutropenia during cancer therapy. The New England journal of medicine. 2013; 368(12): 1131–9.

5. 5) Culakova E, Thota R, Poniewierski MS, Kuderer NM, Wogu AF, Dale DC, Crawford J, Lyman GH. Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study. Cancer medicine. 2014; 3(2): 434–44.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aortitis Associated with Prophylactic Short-acting Granulocyte Colony-stimulating Factor Administration: A Case Report and Review of the Literature;Internal Medicine;2023-06-01